AVBP icon

ArriVent BioPharma
AVBP

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$37
78% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Truist Securities
Truist Securities
Asthika Goonewardene
0% 1-yr AVBP win rate
25 Nov ‘25 8 days ago
Citigroup
Citigroup
Yigal Nochomovitz
100% 1-yr AVBP win rate
11 Nov ‘25 21 days ago